Balance Sheet ICL Group Ltd

Stocks

ICL

IL0002810146

Agricultural Chemicals

Market Closed - NYSE Other stock markets 21:00:03 17/07/2026 BST			5-day change	1st Jan Change
5.050 ^USD	+0.20%		+4.12%	-11.56%

06-23	ICL Signs Agreement for the Supply of Potash to a Customer in India	CI
06-16	Icl Group Ltd. Announces Completion of $800 Million Senior Notes Offering	CI

f2b184d3346a4241ca0abf6950e.2jBwDps-DZIxURhyGqOTNS5p3oFYlYs_lDqH05X2Nco.6FM2PvV_W6BbGCw_aeSgcAMurukc--p03HW2m_ufAL6URkl8z1l48Fhmew

Published financial data: ICL GROUP LTD

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	6.96B	10.02B	7.54B	6.84B	7.15B
Total Revenues	6.96B	10.02B	7.54B	6.84B	7.15B
Cost of Goods Sold, Total	4.34B	4.98B	4.86B	4.58B	4.97B
Gross Profit	2.61B	5.03B	2.67B	2.26B	2.19B
Selling General & Admin Expenses, Total	1.37B	1.43B	1.36B	1.38B	1.44B
R&D Expenses	64M	68M	71M	69M	70M
Other Operating Expenses	10M	7M	114M	15M	-29M
Other Operating Expenses, Total	1.44B	1.51B	1.54B	1.47B	1.48B
Operating Income	1.17B	3.52B	1.13B	787M	704M
Interest Expense, Total	-108M	-138M	-160M	-146M	-148M
Interest And Investment Income	17M	31M	47M	40M	37M
Net Interest Expenses	-91M	-107M	-113M	-106M	-111M
Income (Loss) On Equity Invest.	4M	1M	1M	1M	-
Currency Exchange Gains (Loss)	-79M	139M	37M	-4M	-115M
Other Non Operating Income (Expenses)	77M	-175M	-79M	-13M	122M
EBT, Excl. Unusual Items	1.08B	3.38B	973M	665M	600M
Restructuring Charges	-	-	-	-28M	-167M
Merger & Related Restructuring Charges	-8M	-	-	-	-
Gain (Loss) On Sale Of Investments	14M	22M	-	-	-
Gain (Loss) On Sale Of Assets	10M	9M	1M	2M	-
Asset Writedown	6M	-	-	-	-
Insurance Settlements	-	15M	-	3M	5M
Legal Settlements	-6M	-17M	7M	-4M	-
Other Unusual Items	-6M	-7M	-7M	-2M	3M
EBT, Incl. Unusual Items	1.09B	3.4B	974M	636M	441M
Income Tax Expense	260M	1.18B	287M	172M	161M
Earnings From Continuing Operations	832M	2.22B	687M	464M	280M
Net Income to Company	832M	2.22B	687M	464M	280M
Minority Interest	-49M	-60M	-40M	-57M	-54M
Net Income - (IS)	783M	2.16B	647M	407M	226M
Net Income to Common Incl Extra Items	783M	2.16B	647M	407M	226M
Net Income to Common Excl. Extra Items	783M	2.16B	647M	407M	226M
Per Share Items
Net EPS - Basic	0.61	1.68	0.5	0.32	0.18
Basic EPS - Continuing Operations	0.61	1.68	0.5	0.32	0.18
Basic Weighted Average Shares Outstanding	1.28B	1.29B	1.29B	1.29B	1.29B
Net EPS - Diluted	0.6	1.67	0.5	0.32	0.18
Diluted EPS - Continuing Operations	0.6	1.67	0.5	0.32	0.18
Diluted Weighted Average Shares Outstanding	1.29B	1.29B	1.29B	1.29B	1.29B
Normalized Basic EPS	0.49	1.6	0.44	0.28	0.25
Normalized Diluted EPS	0.49	1.59	0.44	0.28	0.25
Dividend Per Share	0.32	0.91	0.28	0.19	0.18
Payout Ratio	35.25	54.01	73.26	61.67	99.12
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	1.58B	3.94B	1.57B	1.28B	1.22B
EBITA	1.2B	3.56B	1.16B	816M	738M
EBIT	1.17B	3.52B	1.13B	787M	704M
Effective Tax Rate - (Ratio)	23.81	34.81	29.47	27.04	36.51
Total Current Taxes	145M	869M	251M	184M	162M
Total Deferred Taxes	22M	45M	47M	-20M	-15M
Normalized Net Income	627M	2.05B	568M	359M	321M
Interest Capitalized	18M	10M	7M	7M	8M
Non-Cash Pension Expense	4M	-16M	8M	8M	18M
Supplemental Operating Expense Items
Selling and Marketing Expenses	1.07B	1.18B	1.09B	1.11B	1.11B
General and Administrative Expenses	276M	291M	260M	259M	299M
Research And Development Expense From Footnotes	64M	68M	71M	69M	70M
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	6M	12M	7M	10M	12M
Total Stock-Based Compensation	6M	12M	7M	10M	12M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	473M	417M	420M	327M	291M
Short Term Investments	91M	91M	172M	115M	205M
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	564M	508M	592M	442M	496M
Accounts Receivable, Total	1.42B	1.58B	1.38B	1.26B	1.36B
Other Receivables	258M	243M	275M	201M	268M
Total Receivables	1.68B	1.83B	1.65B	1.46B	1.63B
Inventory	1.57B	2.13B	1.7B	1.63B	1.93B
Prepaid Expenses	51M	70M	35M	16M	58M
Other Current Assets, Total	48M	10M	53M	41M	43M
Total Current Assets	3.91B	4.55B	4.03B	3.59B	4.16B
Gross Property Plant And Equipment	12.49B	12.98B	13.77B	14.27B	15.44B
Accumulated Depreciation	-6.74B	-7.01B	-7.44B	-7.81B	-8.65B
Net Property Plant And Equipment	5.75B	5.97B	6.33B	6.46B	6.78B
Long-term Investments	26M	3M	2M	3M	3M
Goodwill	502M	507M	530M	543M	552M
Other Intangibles, Total	365M	345M	343M	326M	403M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	147M	150M	152M	143M	180M
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	377M	228M	237M	258M	326M
Total Assets	11.08B	11.75B	11.63B	11.32B	12.41B
Liabilities
Accounts Payable, Total	1.06B	1.01B	912M	1B	1.16B
Accrued Expenses, Total	592M	634M	488M	546M	615M
Short-term Borrowings	327M	313M	283M	276M	439M
Current Portion of Long-Term Debt	190M	159M	510M	43M	362M
Current Portion of Leases	63M	68M	72M	78M	79M
Current Income Taxes Payable	183M	177M	170M	215M	257M
Unearned Revenue Current, Total	33M	41M	17M	21M	67M
Other Current Liabilities	160M	208M	186M	147M	155M
Total Current Liabilities	2.61B	2.61B	2.64B	2.33B	3.13B
Long-Term Debt	2.14B	2.04B	1.63B	1.73B	1.7B
Long-Term Leases	299M	270M	204M	186M	176M
Pension & Other Post Retirement Benefits	564M	402M	354M	331M	390M
Deferred Tax Liability Non Current	384M	423M	489M	481M	502M
Other Non Current Liabilities	341M	294M	273M	281M	267M
Total Liabilities	6.34B	6.04B	5.59B	5.33B	6.17B
Common Stock, Total	548M	549M	549M	549M	549M
Additional Paid In Capital	224M	233M	234M	238M	240M
Retained Earnings	4.32B	5.38B	5.58B	5.76B	5.77B
Treasury Stock	-260M	-260M	-260M	-260M	-260M
Comprehensive Income and Other	-306M	-443M	-338M	-567M	-315M
Total Common Equity	4.53B	5.46B	5.77B	5.72B	5.98B
Minority Interest	209M	249M	269M	263M	260M
Total Equity	4.74B	5.71B	6.04B	5.99B	6.24B
Total Liabilities And Equity	11.08B	11.75B	11.63B	11.32B	12.41B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.29B	1.29B	1.29B	1.29B	1.29B
ECS Total Common Shares Outstanding	1.29B	1.29B	1.29B	1.29B	1.29B
Book Value / Share	3.52	4.24	4.47	4.44	4.64
Tangible Book Value	3.66B	4.61B	4.9B	4.86B	5.03B
Tangible Book Value Per Share	2.84	3.58	3.8	3.76	3.9
Total Debt	3.02B	2.85B	2.7B	2.31B	2.76B
Net Debt	2.46B	2.34B	2.11B	1.87B	2.26B
Debt Equivalent of Unfunded Proj. Benefit Obligation	345M	232M	200M	161M	167M
Minority Interest, Total (Incl. Fin. Div)	209M	249M	269M	263M	260M
Equity Method Investments, Total	26M	3M	2M	3M	3M
Account Code - Inventory Valuation	6	6	6	6	6
Land - (BS)	1.11B	1.09B	1.14B	1.13B	1.33B
Machinery, Total	7.66B	7.86B	8.28B	8.5B	9.11B
Full Time Employees	12.27K	12.73K	12.55K	12.35K	12.16K
Accumulated Allowance for Doubtful Accounts (Supple)	9M	8M	13M	26M	38M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	783M	2.16B	647M	407M	226M
Depreciation & Amortization - CF	454M	458M	494M	550M	562M
Amortization of Goodwill and Intangible Assets - (CF)	29M	31M	30M	29M	34M
Depreciation & Amortization, Total	483M	489M	524M	579M	596M
Amortization of Deferred Charges, Total - (CF)	7M	9M	12M	17M	19M
(Gain) Loss From Sale Of Asset	-	-	-	-	-
Asset Writedown & Restructuring Costs	-6M	-	-	14M	111M
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Stock-Based Compensation (CF)	-	-	-	-	-
Other Operating Activities, Total	101M	91M	-20M	246M	167M
Change In Accounts Receivable	-426M	-215M	252M	26M	-11M
Change In Inventories	-267M	-527M	465M	-7M	-210M
Change In Accounts Payable	274M	-42M	-101M	104M	100M
Change in Other Net Operating Assets	116M	61M	-184M	82M	58M
Cash from Operations	1.06B	2.02B	1.6B	1.47B	1.06B
Capital Expenditure	-611M	-747M	-780M	-713M	-824M
Sale of Property, Plant, and Equipment	-	-	4M	19M	1M
Cash Acquisitions	-365M	-18M	-	-74M	-12M
Divestitures	31M	-	-	-	-
Investment in Marketable and Equity Securities, Total	-	33M	-	-	-
Other Investing Activities, Total	366M	-22M	-87M	74M	-80M
Cash from Investing	-579M	-754M	-863M	-694M	-915M
Short Term Debt Issued, Total	-	-	-	-	146M
Long-Term Debt Issued, Total	1.23B	1.04B	633M	889M	1.67B
Total Debt Issued	1.23B	1.04B	633M	889M	1.81B
Short Term Debt Repaid, Total	-58M	-21M	-25M	-1M	-
Long-Term Debt Repaid, Total	-1.12B	-1.18B	-836M	-1.3B	-1.6B
Total Debt Repaid	-1.18B	-1.2B	-861M	-1.3B	-1.6B
Common Dividends Paid	-276M	-1.17B	-474M	-251M	-224M
Common & Preferred Stock Dividends Paid	-276M	-1.17B	-474M	-251M	-224M
Other Financing Activities, Total	-20M	20M	-10M	-181M	-184M
Cash from Financing	-244M	-1.3B	-712M	-846M	-195M
Foreign Exchange Rate Adjustments	17M	-24M	-17M	-21M	18M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	259M	-56M	3M	-93M	-36M
Supplemental Items
Cash Interest Paid	89M	-	-	122M	117M
Cash Income Tax Paid (Refund)	193M	1.11B	253M	98M	151M
Levered Free Cash Flow	188M	1.22B	672M	750M	-41.5M
Unlevered Free Cash Flow	256M	1.3B	772M	841M	51M
Change In Net Working Capital	361M	661M	-305M	-456M	192M
Net Debt Issued / Repaid	52M	-157M	-228M	-414M	213M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	7.06	19.29	6.03	4.29	3.71
Return on Total Capital	9.98	26.98	8.14	5.77	5.09
Return On Equity %	18.86	42.47	11.69	7.72	4.58
Return on Common Equity	18.52	43.22	11.52	7.08	3.86
Margin Analysis
Gross Profit Margin %	37.54	50.24	35.44	32.98	30.56
SG&A Margin	19.64	14.31	18.03	20.25	20.15
EBITDA Margin %	22.76	39.33	20.81	18.71	17
EBITA Margin %	17.25	35.5	15.35	11.93	10.32
EBIT Margin %	16.84	35.19	14.95	11.5	9.84
Income From Continuing Operations Margin %	11.96	22.16	9.12	6.78	3.91
Net Income Margin %	11.26	21.56	8.59	5.95	3.16
Net Avail. For Common Margin %	11.26	21.56	8.59	5.95	3.16
Normalized Net Income Margin	9.02	20.51	7.54	5.24	4.49
Levered Free Cash Flow Margin	2.71	12.16	8.92	10.96	-0.58
Unlevered Free Cash Flow Margin	3.68	13.03	10.25	12.29	0.71
Asset Turnover
Asset Turnover	0.67	0.88	0.64	0.6	0.6
Fixed Assets Turnover	1.23	1.71	1.23	1.07	1.08
Receivables Turnover (Average Receivables)	6.05	6.67	5.09	5.19	5.45
Inventory Turnover (Average Inventory)	3.08	2.69	2.54	2.75	2.79
Short Term Liquidity
Current Ratio	1.5	1.75	1.53	1.54	1.33
Quick Ratio	0.86	0.9	0.85	0.82	0.68
Operating Cash Flow to Current Liabilities	0.41	0.78	0.6	0.63	0.34
Days Sales Outstanding (Average Receivables)	60.38	54.69	71.66	70.51	66.97
Days Outstanding Inventory (Average Inventory)	118.47	135.66	143.94	132.87	130.8
Average Days Payable Outstanding	70.59	68.1	78.94	77.7	74.7
Cash Conversion Cycle (Average Days)	108.26	122.24	136.65	125.69	123.08
Long Term Solvency
Total Debt/Equity	63.83	49.92	44.74	38.58	44.21
Total Debt / Total Capital	38.96	33.3	30.91	27.84	30.66
LT Debt/Equity	51.58	40.47	30.41	31.95	30.11
Long-Term Debt / Total Capital	31.49	26.99	21.01	23.06	20.88
Total Liabilities / Total Assets	57.26	51.38	48.08	47.12	49.71
EBIT / Interest Expense	10.84	25.54	7.04	5.39	4.76
EBITDA / Interest Expense	15.31	29.08	10.32	9.36	8.78
(EBITDA - Capex) / Interest Expense	9.66	23.67	5.44	4.47	3.22
Total Debt / EBITDA	1.83	0.71	1.64	1.69	2.12
Net Debt / EBITDA	1.49	0.58	1.28	1.37	1.74
Total Debt / (EBITDA - Capex)	2.9	0.87	3.1	3.54	5.8
Net Debt / (EBITDA - Capex)	2.36	0.72	2.42	2.86	4.76
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	37.91	44	-24.75	-9.22	4.56
Gross Profit, 1 Yr. Growth %	75.23	92.72	-46.92	-15.54	-3.1
EBITDA, 1 Yr. Growth %	111.91	148.83	-60.19	-21.33	-5
EBITA, 1 Yr. Growth %	239.94	196.25	-67.45	-32.89	-9.56
EBIT, 1 Yr. Growth %	252.71	200.94	-68.02	-33.64	-10.55
Earnings From Cont. Operations, 1 Yr. Growth %	3.37K	166.71	-69.04	-32.46	-39.66
Net Income, 1 Yr. Growth %	7.02K	175.73	-70.03	-37.09	-44.47
Normalized Net Income, 1 Yr. Growth %	401.3	227.42	-72.34	-40.72	-10.49
Diluted EPS Before Extra, 1 Yr. Growth %	6.88K	178.33	-70.06	-36.9	-44.5
Accounts Receivable, 1 Yr. Growth %	60.59	11.64	-13.08	-8.43	8.33
Inventory, 1 Yr. Growth %	25.6	35.92	-20.2	-4.52	18.94
Net Property, Plant and Equip., 1 Yr. Growth %	3.68	3.74	6.03	2.1	5
Total Assets, 1 Yr. Growth %	14.65	6.05	-1.05	-2.63	9.65
Tangible Book Value, 1 Yr. Growth %	12.27	26.01	6.14	-0.82	3.56
Common Equity, 1 Yr. Growth %	15.19	20.7	5.56	-0.76	4.52
Cash From Operations, 1 Yr. Growth %	32.46	90.14	-21.23	-14.15	-28.07
Capital Expenditures, 1 Yr. Growth %	-2.4	22.26	4.42	-8.59	15.57
Levered Free Cash Flow, 1 Yr. Growth %	61.7	546.72	-44.81	5.69	-105.63
Unlevered Free Cash Flow, 1 Yr. Growth %	44.97	409.82	-40.79	3.91	-93.85
Dividend Per Share, 1 Yr. Growth %	220.6	194.17	-69.54	-28.52	-7.11
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	14.87	40.92	4.09	-17.35	-2.57
Gross Profit, 2 Yr. CAGR %	19.87	83.77	1.14	-33.04	-9.53
EBITDA, 2 Yr. CAGR %	17.33	119.04	-2.84	-43.63	-15.97
EBITA, 2 Yr. CAGR %	30.28	227.23	-0.6	-51.92	-21.12
EBIT, 2 Yr. CAGR %	28.7	225.8	-1.9	-52.78	-22.96
Earnings From Cont. Operations, 2 Yr. CAGR %	31.52	861.55	-9.13	-54.27	-36.16
Net Income, 2 Yr. CAGR %	28.39	1.3K	-9.1	-56.58	-40.9
Normalized Net Income, 2 Yr. CAGR %	28.12	305.14	-4.83	-58.25	-27.16
Diluted EPS Before Extra, 2 Yr. CAGR %	27.34	1.29K	-8.71	-56.53	-40.82
Accounts Receivable, 2 Yr. CAGR %	35	33.89	-1.49	-10.78	-0.4
Inventory, 2 Yr. CAGR %	9.39	30.66	4.15	-12.71	6.57
Net Property, Plant and Equip., 2 Yr. CAGR %	3.89	3.71	4.88	4.05	3.54
Total Assets, 2 Yr. CAGR %	9.9	10.27	2.44	-1.84	3.32
Tangible Book Value, 2 Yr. CAGR %	5.75	18.94	15.65	2.6	1.35
Common Equity, 2 Yr. CAGR %	7.4	17.91	12.88	2.35	1.85
Cash From Operations, 2 Yr. CAGR %	3.61	58.7	22.38	-17	-21.42
Capital Expenditures, 2 Yr. CAGR %	2.99	9.24	12.99	-2.3	2.78
Levered Free Cash Flow, 2 Yr. CAGR %	-31.08	223.37	88.93	-21.68	-75.81
Unlevered Free Cash Flow, 2 Yr. CAGR %	-25.65	171.86	73.74	-19.83	-74.9
Dividend Per Share, 2 Yr. CAGR %	29.9	201.98	-5.45	-53.95	-19.15
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	7.77	23.86	14.33	-0.55	-10.61
Gross Profit, 3 Yr. CAGR %	12.09	40.43	21.48	-4.75	-24.26
EBITDA, 3 Yr. CAGR %	11.4	50.74	24.07	-8.32	-32.92
EBITA, 3 Yr. CAGR %	17.38	71.32	51.61	-11.34	-40.65
EBIT, 3 Yr. CAGR %	16.43	70.82	50.29	-12.41	-41.58
Earnings From Cont. Operations, 3 Yr. CAGR %	-12.34	66.47	205.9	-17.69	-49.84
Net Income, 3 Yr. CAGR %	-14.21	65.65	288.9	-19.6	-52.87
Normalized Net Income, 3 Yr. CAGR %	17.67	75.16	65.59	-17	-46.17
Diluted EPS Before Extra, 3 Yr. CAGR %	-14.8	65.26	287.5	-19.28	-52.84
Accounts Receivable, 3 Yr. CAGR %	12.72	26.72	15.94	-3.86	-4.82
Inventory, 3 Yr. CAGR %	6.77	17.6	10.86	1.18	-3.23
Net Property, Plant and Equip., 3 Yr. CAGR %	7.26	3.84	4.48	3.94	4.36
Total Assets, 3 Yr. CAGR %	8.08	8.6	6.36	0.72	1.85
Tangible Book Value, 3 Yr. CAGR %	6.76	12.11	14.51	9.88	2.92
Common Equity, 3 Yr. CAGR %	6.19	11.66	13.64	8.13	3.07
Cash From Operations, 3 Yr. CAGR %	19.76	26.85	25.65	11.29	-20.87
Capital Expenditures, 3 Yr. CAGR %	2.22	9.05	7.61	5.28	3.32
Levered Free Cash Flow, 3 Yr. CAGR %	19.15	45.36	79.38	58.47	-67.62
Unlevered Free Cash Flow, 3 Yr. CAGR %	14.43	41.25	63.57	48.67	-66.09
Dividend Per Share, 3 Yr. CAGR %	21.22	68.68	40.47	-14.61	-42.11
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.34	13.07	6.29	5.35	7.24
Gross Profit, 5 Yr. CAGR %	9.48	24.65	7.58	4.42	7.97
EBITDA, 5 Yr. CAGR %	12.33	32.08	6.49	2.17	8.17
EBITA, 5 Yr. CAGR %	19.91	43.22	9.29	2.91	17.32
EBIT, 5 Yr. CAGR %	19.33	42.97	8.72	2.17	16.22
Earnings From Cont. Operations, 5 Yr. CAGR %	37.06	44.93	-11.07	-0.72	63.45
Net Income, 5 Yr. CAGR %	45.04	42.77	-12.2	-3.04	83.04
Normalized Net Income, 5 Yr. CAGR %	14.72	43.97	8.09	-1.26	20.73
Diluted EPS Before Extra, 5 Yr. CAGR %	43.1	42.4	-12.41	-3.14	82.74
Accounts Receivable, 5 Yr. CAGR %	7.98	11.18	6.81	10.12	9.1
Inventory, 5 Yr. CAGR %	4.38	11.72	5.71	4.38	9.12
Net Property, Plant and Equip., 5 Yr. CAGR %	5.95	5.71	6.3	3.92	4.1
Total Assets, 5 Yr. CAGR %	5.32	6.16	5.79	4.3	5.13
Tangible Book Value, 5 Yr. CAGR %	17.37	17.82	10.23	8.21	9.05
Common Equity, 5 Yr. CAGR %	11.95	13.83	8.81	7.84	8.77
Cash From Operations, 5 Yr. CAGR %	1.97	19.04	20.8	8.15	5.6
Capital Expenditures, 5 Yr. CAGR %	-0.67	10.33	6.4	4.36	5.65
Levered Free Cash Flow, 5 Yr. CAGR %	-12.28	39.44	43.27	13.58	-18.65
Unlevered Free Cash Flow, 5 Yr. CAGR %	-9.41	34.92	35.24	12.68	-21.99
Dividend Per Share, 5 Yr. CAGR %	13.53	45.47	9.02	0.31	12.03